Brain cancer prediction in children has taken a significant leap forward, thanks to groundbreaking advancements in artificial intelligence (AI).Recent studies highlight how AI tools can outperform traditional methods in assessing relapse risks among pediatric cancer patients, particularly those with gliomas, a common type of brain tumor.